Received Dec 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
got full blown covid; got full blown covid; sick; This is a spontaneous report received from an Other HCP. A 63-year-old female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), in 2025 as dose 1, single (Batch/Lot number: unknown) at the age of 63 years for covid-19 immunisation. The patient's relevant medical history included: "elevated serum ferritin levels" (unspecified if ongoing), notes: ferritin deposition of the liver; "fatty infiltration of the liver" (unspecified if ongoing); "Cholelithiasis" (unspecified if ongoing), notes: gallbladder wall thickening cannot be excluded in the gallbladder fundus; "low risk (IPSS-R 2.5) MDS with 45% ring sideroblasts as well as SF3B1 and TET2 mutations" (unspecified if ongoing); "low risk (IPSS-R 2.5) MDS with 45% ring sideroblasts as well as SF3B1 and TET2 mutations" (unspecified if ongoing); "low risk (IPSS-R 2.5) MDS with 45% ring sideroblasts as well as SF3B1 and TET2 mutations" (unspecified if ongoing); "anemia" (unspecified if ongoing), notes: erythropoeitin alfa 40k units q2 weeks for her anemia; "fluctuating moderate-severe neutropenia" (unspecified if ongoing); "Paroxysmal atrial fibrillation", start date: 24Feb2023 (unspecified if ongoing), notes: paroxysmal atrial fibrillation/flutter by event monitoring, patient has several EKG /rhythm strip copies confirming same; "paroxysmal arrhythmia" (unspecified if ongoing), notes: flecainide 50 mg b.i.d. along with a reduction and metoprolol dose. She may take a bolus of 2 additional flecainide tablets p.r.n. episode; "Palpitations accompanied by shortness of breath", start date: Sep2022 (unspecified if ongoing); "Palpitations accompanied by shortness of breath", start date: Sep2022 (unspecified if ongoing); "dizziness", start date: Sep2022 (unspecified if ongoing); "presyncope", start date: Sep2022 (unspecified if ongoing); "fatigue", start date: Sep2022 (unspecified if ongoing); "COVID infection", start date: 2022 (unspecified if ongoing); "lightheadedness", start date: Sep2022 (unspecified if ongoing); "antinuclear Ab by multiplex Abnormal" (unspecified if ongoing); "UTI" (unspecified if ongoing), notes: resolved with three days of ciprofloxacin; "bone marrow biopsy", start date: 06Jun2024 (unspecified if ongoing), notes: showing multilineage dysplasia, 59% ring sideroblasts, and no increase in blasts; "bone marrow biopsy", start date: 31Jul2024 (unspecified if ongoing), notes: showing myelodysplastic syndrome with multilineage dysplasia, <5% blasts, and 45%ring sideroblasts; "MDS (myelodysplastic syndrome) (CMS/HCC)", start date: 30Jul2025 (unspecified if ongoing); "Breast biopsy benign", start date: 2010 (unspecified if ongoing); "Breast lift", start date: 2011 (unspecified if ongoing); "Breast reduction surgery", start date: 2011 (unspecified if ongoing); "Nausea" (unspecified if ongoing); "Vomiting" (unspecified if ongoing); "Latex, Natural Rubber" (unspecified if ongoing). Concomitant medication(s) included: ESTRACE; IVERMECTIN oral; TAMBOCOR oral; VALTREX; VITAMIN B12 [CYANOCOBALAMIN] sublingual; VITAMIN D3 oral; ZOFRAN [ONDANSETRON] oral taken for nausea, vomiting. Past drug history included: Diltiazem, reaction(s): "fatigue"; Flecainide, reaction(s): "fatigue"; Eliquis; Metoprolol, reaction(s): "fatigue"; Diltiazem, reaction(s): "Tolerance"; Retacrit, reaction(s): "Lightheadedness", notes: relieved with zofran; Retacrit, reaction(s): "nausea", notes: relieved with zofran; Retacrit, start date: 31Jul2025, for Chemotherapy, notes: injection solution 40,000 Units; Codeine, reaction(s): "Allergies: Codeine"; Moxifloxacin, reaction(s): "Rash". Vaccination history included: pfizer-biontech COVID-19 vaccine (DOSE 1, SINGLE; Lot number: EL3248), administration date: 11Jan2021, when the patient was 59-year-old, for Covid-19 Immunization; pfizer-biontech COVID-19 vaccine (DOSE 2, SINGLE; Lot number: EL8982), administration date: 29Jan2021, when the patient was 59-year-old, for COVID-19 immunization; Covid-19 vaccine, omicron b.1.1.529 mrna (pfizer) (dose number unknown), for Covid-19 Immunization, reaction(s): "Palpitations and Shortness of breath", "Palpitations and Shortness of breath". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2025, outcome "unknown" and all described as "got full blown covid"; ILLNESS (non-serious) with onset 2025, 30 min after the suspect product(s) administration, outcome "unknown", described as "sick". The patient underwent the following laboratory tests and procedures: Alanine aminotransferase (0-55): (31Oct2025) 28, notes: U/L; Alpha 1 globulin: (19Dec2022) 0.1; Alpha 2 globulin: (19Dec2022) 0.5; Anion gap (7.0-16.0): (31Oct2025) 10.0 mmol/L; Anisocytosis: (31Oct2025) Slight; Antinuclear antibody: (12Jul2023) Abnormal; Aspartate aminotransferase (0-40): (31Oct2025) 17, notes: U/L; Beta globulin: (19Dec2022) 0.8; Blood albumin: (19Dec2022) 4.8, notes: above high normal; Blood albumin (3.2-4.6): (31Oct2025) 5.0 (H); Blood alkaline phosphatase (40-120): (31Oct2025) 77, notes: U/L; Blood bilirubin (0.3-1.2): (31Oct2025) 0.8 mg/dl; Blood calcium (8.7-10.7): (31Oct2025) 9.0 mg/dl; Blood chloride (98-108): (31Oct2025) 105 mmol/L; Blood creatinine (0.00-1.19): (31Oct2025) 0.49 mg/dl; Blood folate: (30Jul2025) unknown, notes: 10:27 AM; Blood glucose (70-140): (31Oct2025) 116 mg/dl; Blood iron: (30Apr2024) 142, notes: above high normal; (24Sep2025) 321, notes: high; (29Sep2025) abnormal; Blood magnesium: (19Dec2022) Unknown, notes: 10:27 AM; Blood potassium (3.5-5.0): (31Oct2025) 4.1 mmol/L; Blood pressure measurement: (31Oct2025) 129/82; Blood sodium (136-144): (31Oct2025) 140 mmol/L; Blood thyroid stimulating hormone: (31May2023) Unknown; (21Jul2025) Normal; Blood urea (8-20): (31Oct2025) 9 mg/dl; Body mass index: (31Oct2025) 29.24 kg/m2; Body temperature: (31Oct2025) 98.2 Fahrenheit, notes: 36.8 C; Carbohydrate antigen 125: (19Dec2022) Unknown, notes: 10:27 AM; Carbon dioxide (22-29): (31Oct2025) 25 mmol/L; CHA2DS2-VASc-score: (unspecified date) 1, notes: Low; C-reactive protein: (12Jul2023) unknown; Echocardiogram: (unspecified date) EF of 55-60%, normal aortic valve, notes: EF of 55-60%, normal aortic valve, 1-2+ tricuspid insufficiency with RVSP of 27 mmHg, mild 1+ MR. Normal diastolic function; Electrocardiogram: (unspecified date) NSR (76/m); (03Apr2023) normal-sinus rhythm at 68 per minute; Fluorescent in situ hybridisation: (unspecified date) Karyotype showed a normal female karyotype, notes: Karyotype showed a normal female karyotype without abnormalities; Full blood count: (29Sep2025) abnormal; (12Mar2024) abnormal; Gamma-glutamyltransferase: (12Jul2023) Unknown; Glomerular filtration rate: (31Oct2025) 106.1, notes: >=60.0 mL/min/1.73m*2; Glycosylated haemoglobin: (21Jul2025) normal; Haematocrit: (12Mar2024) 28.3, notes: below low normal; (29Sep2025) 26.8, notes: low; Haematocrit (37.0-48.0): (31Oct2025) 27.2 (L); Haemoglobin: (12Mar2024) 9.8, notes: below low normal; (24Sep2025) abnormal, 9.6, notes: 08:16 AM, low; (29Sep2025) 9.0, notes: low; Haemoglobin (11.5-15.7): (31Oct2025) 9.3 (L); Heart rate: (31Oct2025) 70; Immunoglobulins: (19Dec2022) 0.7; Iron binding capacity total: (30Apr2024) abnormal, 357; (24Sep2025) abnormal, 329, notes: 08:16 AM; Iron binding capacity unsaturated: (30Apr2024) 215; Lipids: (21Jul2025) normal; Lymphocyte count: (29Sep2025) 1662, notes: normal; Lymphocyte count (19-45): (31Oct2025) 54 (H); Lymphocyte count (1.10-3.50): (31Oct2025) 1.95, notes: 10*3/uL; Lymphocyte morphology abnormal: (31Oct2025) 0.47, notes: 10*3/uL; Lymphocyte morphology abnormal: (31Oct2025) 13%; Magnetic resonance imaging: (09Jan2023) fatty infiltration of the liver, notes: and also with ferritin deposition of the liver. Cholelithiasis or gallbladder wall thickening. Mild increased signal intensity on T1-weighted images and mild decreased signal intensity on T2-weighted images; Mammogram: (05Feb2025) No mammographic features of malignancy, notes: stable post reduction changes in both breasts. Biopsy clip in the left breast. There is no suspicious mass, cluster of microcalcifications, or architectural distortion; Mean cell haemoglobin: (12Mar2024) 33.9, notes: above high normal; (29Sep2025) 33.5, notes: high; Mean cell haemoglobin (25.6-32.2): (31Oct2025) 33.9 (H); Mean cell haemoglobin concentration: (29Sep2025) 33.6, notes: normal; Mean cell haemoglobin concentration (30.0-35.0): (31Oct2025) 34.2 g/dl; Mean cell volume: (12Mar2024) 98, notes: above high normal; (29Sep2025) 99.6, notes: normal; Mean cell volume (81.0-98.0): (31Oct2025) 99.3 (H), notes: fL; Mean platelet volume: (29Sep2025) 11.3, notes: normal; Mean platelet volume (9.4-12.4): (31Oct2025) 11.3, notes: fL; Metabolic function test: (29Sep2025) abnormal; Monoclonal immunoglobulin: (19Dec2022) not; Monocyte count: (29Sep2025) 422, notes: normal; Monocyte count (4-12): (31Oct2025) 6%; Monocyte count (0.30-0.90): (31Oct2025) 0.22 (L), notes: 10*3/uL; Neutrophil count: (29Sep2025) 989, notes: low; Neutrophil count (40-71): (31Oct2025) 27 (L); Neutrophil count (2.00-7.00): (31Oct2025) 0.98 (L), notes: 10*3/uL, Absolute Neutrophil Count (Segs+Bands); Next-generation sequencing: (unspecified date) mutations in SF3B1 and TET2; Oxygen saturation: (31Oct2025) 98%; Platelet count: (29Sep2025) 238, notes: normal; Platelet count (150-400): (31Oct2025) 249, notes: 10*3/uL; Platelet morphology: (31Oct2025) Normal; Poikilocytosis: (31Oct2025) Slight; Protein total (6.2-8.1): (31Oct2025) 6.8 g/dl; Protein total: (19Dec2022) Abnormal, 7.0, notes: 10:27 AM; Red blood cell count: (12Mar2024) 2.89, notes: below low normal; (29Sep2025) 2.69, notes: low; Red blood cell count (4.00-5.30): (31Oct2025) 2.74 (L); Red blood cell nucleated morphology: (31Oct2025) 0.02, notes: <0.10; Red blood cell nucleated morphology: (31Oct2025) 0.6%, notes: <1.0%; Red cell distribution width: (29Sep2025) 21.9, notes: high; Red cell distribution width (11.0-14.4): (31Oct2025) 23.5 (H); Red cell distribution width (36.0-47.0): (31Oct2025) 81.9 (H), notes: fL; SARS-CoV-2 antibody test: (24Aug2023) unknown, notes: 10:34 AM; Serum ferritin: (30Jul2025) abnormal, 811, notes: 10:27 AM, high; Thyroid function test: (27Feb2023) Unknown; Transferrin: (22Dec2022) Unknown; (24Sep2025) 235; Transferrin saturation: (30Apr2024) 40; (24Sep2025) 98, notes: high; Vitamin B12: (13Jan2025) abnormal, notes: 08:12AM; White blood cell count: (12Mar2024) 3.8; (29Sep2025) 3.1, notes: low; White blood cell count (4.00-10.00): (31Oct2025) 3.62 (L), notes: 10*3/uL; White blood cell scan: (31Oct2025) Normal.; Sender's Comments: Vaccine efficacy varies from person to person and is affected by many factors. The association between the reported serious events of "got full blown covid" with the suspect product BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA) cannot be fully excluded.
Medical History/Concurrent Conditions: Anemia (erythropoeitin alfa 40k units q2 weeks for her anemia); Antinuclear factor abnormal; Bone marrow biopsy (showing myelodysplastic syndrome with multilineage dysplasia, <5% blasts, and 45%ring sideroblasts); Bone marrow biopsy (showing multilineage dysplasia, 59% ring sideroblasts, and no increase in blasts); Breast biopsy; Breast reduction; Cholelithiasis (gallbladder wall thickening cannot be excluded in the gallbladder fundus); COVID-19; Dizziness; Fatigue; Fatty liver infiltration; Latex allergy; Lightheadedness; Mastopexy; MDS; Nausea; Neutropenia; Palpitations; Paroxysmal arrhythmia (flecainide 50 mg b.i.d. along with a reduction and metoprolol dose. She may take a bolus of 2 additional flecainide tablets p.r.n. episode); Paroxysmal atrial fibrillation (paroxysmal atrial fibrillation/flutter by event monitoring, patient has several EKG /rhythm strip copies confirming same); Presyncope; Serum ferritin increased (ferritin deposition of the liver); SF3B1 gene mutation; Shortness of breath; TET2 gene mutation; UTI (resolved with three days of ciprofloxacin); Vomiting
ESTRACE; IVERMECTIN; TAMBOCOR; VALTREX; VITAMIN B12 [CYANOCOBALAMIN]; VITAMIN D3; ZOFRAN [ONDANSETRON]
Test Date: 20251031; Test Name: ALT (SGPT); Result Unstructured Data: Test Result: 28; Comments: U/L; Test Date: 20221219; Test Name: alpha-1-globulin; Result Unstructured Data: Test Result: 0.1; Test Date: 20221219; Test Name: alpha-2-globulin; Result Unstructured Data: Test Result: 0.5; Test Date: 20251031; Test Name: Anion gap; Result Unstructured Data: Test Result: 10.0 mmol/L; Test Date: 20251031; Test Name: Anisocytosis; Result Unstructured Data: Test Result: Slight; Test Date: 20230712; Test Name: antinuclear Ab by multiplex; Result Unstructured Data: Test Result: Abnormal; Test Date: 20251031; Test Name: AST; Result Unstructured Data: Test Result:17; Comments: U/L; Test Date: 20221219; Test Name: beta globulin; Result Unstructured Data: Test Result:0.8; Test Date: 20221219; Test Name: albumin; Result Unstructured Data: Test Result: 4.8; Comments: above high normal; Test Date: 20251031; Test Name: Albumin (g/dl) In Ser/Plas; Result Unstructured Data: Test Result: 5.0 (H) g/dl; Test Date: 20251031; Test Name: Alkaline Phosphatase; Result Unstructured Data: Test Result: 77; Comments: U/L; Test Date: 20251031; Test Name: Total Bilirubin; Test Result: 0.8 mg/dl; Test Date: 20251031; Test Name: Calcium; Test Result: 9.0 mg/dl; Test Date: 20251031; Test Name: Chloride; Result Unstructured Data: Test Result: 105 mmol/L; Test Date: 20251031; Test Name: Creatinine; Test Result: 0.49 mg/dl; Test Date: 20250730; Test Name: folate, RBC; Result Unstructured Data: Test Result: unknown; Comments: 10:27 AM; Test Date: 20251031; Test Name: Glucose; Test Result: 116 mg/dl; Test Date: 20240430; Test Name: Iron; Result Unstructured Data: Test Result: 142; Comments: above high normal; Test Date: 20250924; Test Name: Iron; Result Unstructured Data: Test Result: 321; Comments: high; Test Date: 20250929; Test Name: Iron, TIBC and ferritin panel; Result Unstructured Data: Test Result: abnormal; Test Date: 20221219; Test Name: magnesium; Result Unstructured Data: Test Result: Unknown; Comments: 10:27 AM; Test Date: 20251031; Test Name: Potassium; Result Unstructured Data: Test Result: 4.1 mmol/L; Test Date: 20251031; Test Name: BP; Result Unstructured Data: Test Result: 129/82; Test Date: 20251031; Test Name: Sodium; Result Unstructured Data: Test Result: 140 mmol/L; Test Date: 20230531; Test Name: TSH-004259-P; Result Unstructured Data: Test Result: Unknown; Test Date: 20250721; Test Name: TSH-004259-P; Result Unstructured Data: Test Result: Normal; Test Date: 20251031; Test Name: BUN; Test Result: 9 mg/dl; Test Date: 20251031; Test Name: BMI; Result Unstructured Data: Test Result: 29.24 kg/m2; Test Date: 20251031; Test Name: Temp; Result Unstructured Data: Test Result: 98.2 Fahrenheit; Comments: 36.8 C; Test Date: 20221219; Test Name: Cancer antigen (Ca) 125; Result Unstructured Data: Test Result: Unknown; Comments: 10:27 AM; Test Date: 20251031; Test Name: CO2; Result Unstructured Data: Test Result: 25 mmol/L; Test Name: chads Vasc score; Result Unstructured Data: Test Result: 1; Comments: Low; Test Date: 20230712; Test Name: C-reactive protein, quant; Result Unstructured Data: Test Result: unknown; Test Name: echo; Result Unstructured Data: Test Result: EF of 55-60%, normal aortic valve; Comments: EF of 55-60%, normal aortic valve, 1-2+ tricuspid insufficiency with RVSP of 27 mmHg, mild 1+ MR. Normal diastolic function; Test Name: ECG; Result Unstructured Data: Test Result: NSR (76/m); Test Date: 20230403; Test Name: EkG; Result Unstructured Data: Test Result: normal-sinus rhythm at 68 per minute; Test Name: MDS FISH panel; Result Unstructured Data: Test Result: Karyotype showed a normal female karyotype; Comments: Karyotype showed a normal female karyotype without abnormalities; Test Date: 20250929; Test Name: CBC (includes diff/plt); Result Unstructured Data: Test Result: abnormal; Test Date: 20240312; Test Name: CBC, platelet, no differential; Result Unstructured Data: Test Result: abnormal; Test Date: 20230712; Test Name: GGT; Result Unstructured Data: Test Result: Unknown; Test Date: 20251031; Test Name: eGFR; Result Unstructured Data: Test Result:106.1; Comments: >=60.0 mL/min/1.73m*2; Test Date: 20250721; Test Name: hemoglobin A1C; Result Unstructured Data: Test Result: normal; Test Date: 20240312; Test Name: hematocrit; Result Unstructured Data: Test Result:28.3; Comments: below low normal; Test Date: 20250929; Test Name: hematocrit; Result Unstructured Data: Test Result:26.8; Comments: low; Test Date: 20251031; Test Name: Hematocrit; Result Unstructured Data: Test Result: 27.2 (L)%; Test Date: 20240312; Test Name: hemoglobin; Result Unstructured Data: Test Result: 9.8; Comments: below low normal; Test Date: 20250924; Test Name: hemoglobin; Result Unstructured Data: Test Result: abnormal, 9.6; Comments: 08:16 AM, low; Test Date: 20250929; Test Name: hemoglobin; Result Unstructured Data: Test Result: 9.0; Comments: low; Test Date: 20251031; Test Name: Hemoglobin; Result Unstructured Data: Test Result: 9.3 (L) g/dl; Test Date: 20251031; Test Name: Pulse; Result Unstructured Data: Test Result:70; Test Date: 20221219; Test Name: gamma globulin; Result Unstructured Data: Test Result:0.7; Test Date: 20240430; Test Name: iron and TIBC; Result Unstructured Data: Test Result: abnormal, 357; Test Date: 20250924; Test Name: TIBC (total iron-binding capacity) serum; Result Unstructured Data: Test Result: abnormal, 329; Comments: 08:16 AM; Test Date: 20240430; Test Name: UIBC; Result Unstructured Data: Test Result:215; Test Date: 20250721; Test Name: lipid panel standard; Result Unstructured Data: Test Result: normal; Test Date: 20250929; Test Name: absolute lymphocytes; Result Unstructured Data: Test Result: 1662; Comments: normal; Test Date: 20251031; Test Name: Lymphocytes %; Result Unstructured Data: Test Result: 54 (H)%; Test Date: 20251031; Test Name: Lymphocytes, absolute; Result Unstructured Data: Test Result:1.95; Comments: 10*3/uL; Test Date: 20251031; Test Name: Atypical Lymphocytes, absolute; Result Unstructured Data: Test Result:0.47; Comments: 10*3/uL; Test Date: 20251031; Test Name: Atypical Lymphocytes, relative; Test Result: 13%; Test Date: 20230109; Test Name: MR-Abdomen with and without contrast; Result Unstructured Data: Test Result: fatty infiltration of the liver; Comments: and also with ferritin deposition of the liver. Cholelithiasis or gallbladder wall thickening. Mild increased signal intensity on T1-weighted images and mild decreased signal intensity on T2-weighted images; Test Date: 20250205; Test Name: Screening 3D Mammo Tomosynthesis; Result Unstructured Data: Test Result: No mammographic features of malignancy; Comments: stable post reduction changes in both breasts. Biopsy clip in the left breast. There is no suspicious mass, cluster of microcalcifications, or architectural distortion; Test Date: 20240312; Test Name: MCH; Result Unstructured Data: Test Result: 33.9; Comments: above high normal; Test Date: 20250929; Test Name: MCH; Result Unstructured Data: Test Result: 33.5; Comments: high; Test Date: 20251031; Test Name: MCH; Result Unstructured Data: Test Result: 33.9 (H) pg; Test Date: 20250929; Test Name: MCHC; Result Unstructured Data: Test Result: 33.6; Comments: normal; Test Date: 20251031; Test Name: MCHC; Result Unstructured Data: Test Result: 34.2 g/dl; Test Date: 20240312; Test Name: MCV; Result Unstructured Data: Test Result: 98; Comments: above high normal; Test Date: 20250929; Test Name: MCV; Result Unstructured Data: Test Result: 99.6; Comments: normal; Test Date: 20251031; Test Name: MCV; Result Unstructured Data: Test Result: 99.3 (H); Comments: fL; Test Date: 20250929; Test Name: MPV; Result Unstructured Data: Test Result:11.3; Comments: normal; Test Date: 20251031; Test Name: MPV; Result Unstructured Data: Test Result: 11.3; Comments: fL; Test Date: 20250929; Test Name: comprehensive metabolic panel; Result Unstructured Data: Test Result: abnormal; Test Date: 20221219; Test Name: M-Spike; Result Unstructured Data: Test Result: not; Test Date: 20250929; Test Name: absolute monocytes; Result Unstructured Data: Test Result:422; Comments: normal; Test Date: 20251031; Test Name: Monocytes %; Test Result: 6%; Test Date: 20251031; Test Name: Monocytes, absolute; Result Unstructured Data: Test Result: 0.22 (L); Comments: 10*3/uL; Test Date: 20250929; Test Name: absolute neutrophils; Result Unstructured Data: Test Result: 989; Comments: low; Test Date: 20251031; Test Name: Neutrophils %; Result Unstructured Data: Test Result: 27 (L) %; Test Date: 20251031; Test Name: Neutrophils, absolute; Result Unstructured Data: Test Result:0.98 (L); Comments: 10*3/uL, Absolute Neutrophil Count (Segs+Bands); Test Name: Myeloid NGS panel; Result Unstructured Data: Test Result: mutations in SF3B1 and TET2; Test Date: 20251031; Test Name: Spo2; Test Result: 98%; Test Date: 20250929; Test Name: platelet count; Result Unstructured Data: Test Result: 238; Comments: normal; Test Date: 20251031; Test Name: Platelets; Result Unstructured Data: Test Result: 249; Comments: 10*3/uL; Test Date: 20251031; Test Name: PLT Morphology; Result Unstructured Data: Test Result: Normal; Test Date: 20251031; Test Name: Poikilocytes; Result Unstructured Data: Test Result: Slight; Test Date: 20251031; Test Name: Protein; Result Unstructured Data: Test Result: 6.8 g/dl; Test Date: 20221219; Test Name: Protein electro S; Result Unstructured Data: Test Result: Abnormal, 7.0; Comments: 10:27 AM; Test Date: 20240312; Test Name: RBC; Result Unstructured Data: Test Result: 2.89; Comments: below low normal; Test Date: 20250929; Test Name: RBC; Result Unstructured Data: Test Result: 2.69; Comments: low; Test Date: 20251031; Test Name: RBC; Result Unstructured Data: Test Result:2.74 (L) 10*6/uL; Test Date: 20251031; Test Name: Absolute NRBCs; Result Unstructured Data: Test Result:0.02; Comments: <0.10; Test Date: 20251031; Test Name: NRBCs % Auto; Test Result: 0.6%; Comments: <1.0%; Test Date: 20250929; Test Name: RDW; Result Unstructured Data: Test Result: 21.9; Comments: high; Test Date: 20251031; Test Name: RDW; Result Unstructured Data: Test Result: 23.5 (H)%; Test Date: 20251031; Test Name: RDW-SD; Result Unstructured Data: Test Result: 81.9 (H); Comments: fL; Test Date: 20230824; Test Name: sars-cov-2 sem-quant spike AB; Result Unstructured Data: Test Result: unknown; Comments: 10:34 AM; Test Date: 20250730; Test Name: ferritin, serum or plasma; Result Unstructured Data: Test Result: abnormal, 811; Comments: 10:27 AM, high; Test Date: 20230227; Test Name: T3f+T4F+TSH; Result Unstructured Data: Test Result: Unknown; Test Date: 20221222; Test Name: transferrin; Result Unstructured Data: Test Result: Unknown; Test Date: 20250924; Test Name: transferrin; Result Unstructured Data: Test Result:235; Test Date: 20240430; Test Name: iron saturation; Result Unstructured Data: Test Result:40; Test Date: 20250924; Test Name: iron saturation; Result Unstructured Data: Test Result:98; Comments: high; Test Date: 20250113; Test Name: vitamin B12; Result Unstructured Data: Test Result: abnormal; Comments: 08:12AM; Test Date: 20240312; Test Name: WBc; Result Unstructured Data: Test Result:3.8; Test Date: 20250929; Test Name: WBc; Result Unstructured Data: Test Result:3.1; Comments: low; Test Date: 20251031; Test Name: WBC Automated; Result Unstructured Data: Test Result:3.62 (L); Comments: 10*3/uL; Test Date: 20251031; Test Name: WBC Morphology; Result Unstructured Data: Test Result: Normal